Lintbells Launch State Of Art Study Into Canine Osteoarthritis

The revolutionary monitoring device that will be used in the trial. A revolutionary activity monitoring and analysis technique developed by scientists at the Royal Veterinary College (RVC) is being used for the first time in a new clinical study into canine osteoarthritis (OA). The state of the art recorder attaches to the dog’s collar and uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog’s location, allowing constant recording of movement in the dog’s home environment, to complement the traditional clinical assessments carried out by veterinary professionals as part of the trial. The RVC is working with nutritional supplements firm Lintbells in order to investigate the efficacy of its joint and mobility supplement Yumove in reducing the clinical signs of osteoarthritis. The aim of the 12 week study is to advance the treatment of canine OA in veterinary medicine. The analysis software has been developed specifically for the trial and will allow it to be the first time the real effect of a joint supplement has been measured. Co-founder of Lintbells Dr John Howie said: “This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect.” Patients are now being sought to take part in the trial. Dogs eligible for the study must already have a diagnosis of OA which will be confirmed at the Queen Mother Hospital for Animals, near Potters Bar. The research is being led by Dr Matthew Pead the RVC’s Academic Director of Professional Assessment and Development. He commented: “The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs.” Any veterinarian with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College – email [email protected] or phone 01707 666605.

More from

• West Midlands communications agency celebrates quartet of award nominations for work in veterinary sector
• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits